We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Chagas Disease Unfamiliar to Many U.S. Physicians

By LabMedica International staff writers
Posted on 26 Oct 2010
Print article
Image: Trypanosoma cruzi, the causative agent of Chagas disease, in a thin blood film (photo courtesy Centers for Disease Control and Prevention [CDC]).
Image: Trypanosoma cruzi, the causative agent of Chagas disease, in a thin blood film (photo courtesy Centers for Disease Control and Prevention [CDC]).
Chagas disease manifests both as an acute or chronic disease, caused by the parasitic protozoa Trypanosoma cruzi and should no longer be thought of as exotic.

The diagnosis of Chagas disease can be made by observation of the parasite in a blood smear by microscopic examination. A thick and thin blood smear are made and stained for visualization of parasites. However, a blood smear works well only in the acute phase of infection when parasites are seen circulating in blood. For screening blood donated for transfusion, antibody detection tests are available.

The disease is spread by infected insects called triatomine bugs and is only transmitted on the American continents. Infection can also occur through blood transfusions, ingestion of contaminated food or drink, organ transplants, and from an infected mother to her unborn child. For obstetricians and gynecologists in the U.S., increased awareness around Chagas disease is important because many newly diagnosed patients are identified among blood donors who are women of childbearing age and at risk of transmitting the infection to their newborns. Although congenital Chagas disease is relatively rare in the US, the estimated 300 annual cases are similar to other rare diseases for which all newborns in the U.S. are routinely screened at birth.

A survey published in the October 2010 issue of the American Journal of Tropical Medicine and Hygiene, revealed that knowledge and understanding of this condition is low among obstetrician-gynecologists. The survey results found that only 3% of the physicians surveyed considered their knowledge about Chagas disease excellent or good compared to a large majority (88%) who described their knowledge as limited or very limited; almost 10% of those surveyed reported never having heard of the disease at all. One-third of survey respondents did not know what causes the disease, and only 58% were able to identify it correctly as a parasitic infection.

Jennifer R. Verani, M.D., from the Center for Disease Control and Prevention (CDC; Atlanta, GA; USA), said, "The good news about the survey results is that the majority of physicians respondents were not misinformed, they just did not have information about Chagas disease.” Edward T. Ryan, M.D., President of American Society of Tropical Medicine and Hygiene, added, "There are potentially 100,000 women living in the U.S. who are at risk of infecting their unborn babies. We need to educate obstetricians, family practitioners, nurse midwives, and pediatricians about Chagas, especially those who care for families from Latin America."

If left untreated, Chagas disease can cause complications such as cardiomyopathy, heart disease, heart failure, enlargement of the colon, enlargement of the esophagus and malnutrition. An estimated 20% to 30% of patients will develop the cardiovascular/digestive complications, decades after the initial infection.

Related Links:

CDC

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more